期刊文献+

高效液相色谱法测定人脑脊液中比阿培南的浓度及临床应用 被引量:2

Determination of biapenem in human cerebrospinal fluid by HPLC and its clinical application
原文传递
导出
摘要 目的:建立一种高效液相色谱法测定人脑脊液中比阿培南浓度并应用于颅内感染的个体化治疗。方法:采用外标法,色谱柱为Shim-packVP-ODS柱,流动相为乙腈-0.1mol·L^-1醋酸钠缓冲液(2:98,pH4.6),流速为1.0ml·min^-1,检测波长300nm,柱温为30℃,并利用建立的方法对颅内感染患者进行药物浓度监测。结果:比阿培南在0.2~50mg·L^-1范围内线性良好(r=0.9994),定量下限为O.2mg·L^-1低、中、高(0.5,5,25mg·L^-1)质量浓度日内和El间RSD均≤10%,回收率在85%~110%之间,均满足生物样品测定要求。结论:本法简便快速准确,适用于比阿培南脑脊液浓度测定。 OBJECTIVE To establish an HPLC method for determination of biapenem in human cerebrospinal and apply it to the therapy of intracranial infection. METHODS The chromatographical column was Shim-pack VP-ODS, the mobile phase consisted of acetonitile-0. 1 mol.L^-1 sodium acetate buffer solution (2:98, pH 4. 6), the flow rate was 1.0 ml.min ^-1. The de tection wavelength was set at 300 nm, temperature was kept at 30 ℃. And biapenem concentrations in CSF of patients with in tracranial infection were monitored by this way. RESULTS Biapenem showed a good linear relation in the range of 0. 2 - 50 mg . L^-1 (r=0. 999 4) ,the limit of quantitation was 0. 2 mg.L^-1. At 0.5,5,25 mg.L ^-1 ,the intra-day and inter-day RSD were less than 10%, the recoveries were between 85% - 110%, all met the criteria for determination of biological samples. CONCLU SION The method is simple,rapid and precise,it is suitable for determination of biapenem in human cerebrospinal fluid.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2014年第5期364-366,共3页 Chinese Journal of Hospital Pharmacy
基金 广西科学研究与技术开发计划项目(编号:桂科攻1140003A-43)
关键词 高效液相色谱法 比阿培南 脑脊液浓度 HPLC biapeneml drug concentration of cerebrospinal fluid(CSF)
  • 相关文献

参考文献5

二级参考文献36

  • 1林东昉,吴菊芳,张婴元,郑经川,缪竞智,郑丽叶,盛瑞媛,周新,沈华浩,吴卫红,周乐,汪复.利奈唑胺与万古霉素治疗革兰阳性菌感染的随机、双盲、对照、多中心临床试验[J].中国感染与化疗杂志,2009,9(1):10-17. 被引量:57
  • 2赵敏,赵国君,张勇.新碳青霉烯类抗生素比阿培南[J].中国临床药理学杂志,2005,21(5):390-392. 被引量:26
  • 3王强,于作华,杨莉,沈凯,刘敏,石广志,周建新.神经外科手术对头孢吡肟脑脊液浓度的影响[J].中国临床药理学杂志,2005,21(6):410-413. 被引量:3
  • 4张涛,曾跃斌,胡丽娜,钱元恕.2003-2004年注射用抗菌药应用状况调查[J].药物流行病学杂志,2006,15(2):93-95. 被引量:9
  • 5Bonfiglio C, Macearone G, Mezzatesta ML, et al. In vitro activity of biapenem against recent gram negative and gram-positive clinical isolates[J]. Chemotherapy, 1997, 43:393.
  • 6Kozawa O, Uematsu T, Matsuna H. Pharmaeokinetics and safety of a new parenteral carbapenem antibiotic biapenem[J]. Elderly Subjucts An Agent Chemth, 1998, 42 : 1443-1436.
  • 7Ikeda K, Ikawa K, Ikeda A, et al. A simple and rapid determination of biapenem in plasma by high-perforance liquid chromatography [J]. J Chromatogr B, 2006, 844:148-152.
  • 8Igari J,Watanabe M,Uehara N.Changes in the antibacterial activity of chemotherapeutic agents(especially carbapenems) for 10 species of clinical isolates between 1994 and 1996.Surveillance group ofthe sensitivities of clinical isolates to antibacterial agents[J].Jpn J Antibiot,2000,53(3):157.
  • 9Suzuki Y,Nishinari C,Endo H.Antimicrobial activities of carbapenems and forth generation eephems against clinically isolated strains[J].Jpn J Antibiot,2001,54(9):473.
  • 10Watanabe A,Tokue Y,Takahashi H,et al.In vitro activity of biapenem(BIPM)against clinically isolated respiratory pathogens in 1996-1998[J].Jpn J Antibiot,1999,52(12):690.

共引文献45

同被引文献16

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部